sec filing
VM
NASDAQ · VMD
Viemed Healthcare, Inc.
Healthcare · Medical - Devices
$8.75
Up+$0.11 (+1.26%)
Updated Sep 16, 2026, 6:07 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 285.26M
- P/E ratio
- 20.66
- Dividend yield
- 0.00%
- 52-week range
- $6.05 – $12.61
- Volume
- 178.39K
- Avg. volume
- 163.27K
Price performance
VMD price history
1M range · 20 trading sessions · Daily adjusted prices
VMD closed at $8.75 after 20 trading sessions, down 4.06% for the selected period.
- Last close
- $8.75
- Period change
- -4.06%
- Period low
- $8.57
- Period high
- $9.33
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $8.82 | $8.82 | $8.70 | $8.75 | 178.39K |
| Sep 14, 2026 | $8.83 | $8.98 | $8.76 | $8.84 | 226.38K |
| Sep 11, 2026 | $8.81 | $8.92 | $8.7006 | $8.79 | 202.21K |
| Sep 10, 2026 | $8.74 | $8.819 | $8.695 | $8.75 | 236.63K |
| Sep 9, 2026 | $8.73 | $8.84 | $8.595 | $8.76 | 399.4K |
| Sep 8, 2026 | $8.85 | $8.99 | $8.74 | $8.79 | 335.58K |
| Sep 4, 2026 | $9.03 | $9.13 | $8.95 | $9.08 | 185.58K |
| Sep 3, 2026 | $9.00 | $9.0409 | $8.86 | $9.01 | 153.12K |
| Sep 2, 2026 | $8.79 | $9.01 | $8.79 | $8.98 | 280.45K |
| Sep 1, 2026 | $8.83 | $8.92 | $8.69 | $8.80 | 354.08K |
| Aug 31, 2026 | $8.988 | $8.988 | $8.71 | $8.84 | 338.07K |
| Aug 28, 2026 | $9.02 | $9.23 | $8.785 | $8.82 | 294.11K |
| Aug 27, 2026 | $9.26 | $9.37 | $8.99 | $9.01 | 327.84K |
| Aug 26, 2026 | $9.20 | $9.39 | $9.05 | $9.33 | 273.42K |
| Aug 25, 2026 | $8.987 | $9.174 | $8.97 | $9.10 | 331.26K |
| Aug 24, 2026 | $9.01 | $9.17 | $8.94 | $9.09 | 488.38K |
| Aug 21, 2026 | $8.61 | $8.905 | $8.51 | $8.85 | 1.07M |
| Aug 20, 2026 | $8.93 | $8.95 | $8.55 | $8.57 | 432.83K |
| Aug 19, 2026 | $9.05 | $9.10 | $8.885 | $8.94 | 421.34K |
| Aug 18, 2026 | $9.13 | $9.17 | $8.985 | $9.12 | 432.58K |
Latest VMD news
The latest Smart Investors Daily articles mentioning VMD.
Stock researchResearch & News · SEC Filings
Loading stock research…